Citadel Advisors »

Bioage Labs shares owned by Citadel Advisors

Quarter-by-quarter ownership of Bioage Labs (BIOA) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Bioage Labs

Tip: Access up to 7 years of quarterly data

All positions including Bioage Labs held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bioage Labs by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $873k 149k 5.88
2025-06-30 $553k 134k 4.13
2024-09-30 $4.4M 214k 20.80

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Apple Call Option (AAPL)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation Call Option (MSFT)
Spdr Gold Tr Gold Shs Call Option (GLD)
Ishares Tr Russell 2000 Etf (IWM)
Amazon Call Option (AMZN)
Strategy Cl A New Call Option (MSTR)
Alphabet Cap Stk Cl A Call Option (GOOGL)
UnitedHealth Call Option (UNH)
Palantir Technologies Cl A Call Option (PLTR)
Netflix Call Option (NFLX)

View all positions for Citadel Advisors

Top funds holding Bioage Labs

AH Capital Management
Sofinnova Ventures
Cormorant Asset Management
ADAR1 Capital Management
Vanguard Group
Tang Capital Management
BlackRock
OrbiMed Advisors
Sands Capital Ventures
Pivotal bioVenture Partners Investment Advisor
Geode Capital Management
Redpoint Management
Siren
Millennium Management
Comprehensive Financial Management

View all funds holding Bioage Labs